Page last updated: 2024-10-26

dimaprit and Experimental Neoplasms

dimaprit has been researched along with Experimental Neoplasms in 2 studies

Dimaprit: A histamine H2 receptor agonist that is often used to study the activity of histamine and its receptors.

Research Excerpts

ExcerptRelevanceReference
"-injected B16 melanoma (F1 and F10 strain) cells in Swiss albino, C57BL/6, and BALB/c mice was reduced by a single dose of histamine given 24 h before tumor cell inoculation."3.68Role of histamine in natural killer cell-mediated resistance against tumor cells. ( Asea, A; Hellstrand, K; Hermodsson, S, 1990)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hellstrand, K1
Asea, A1
Hermodsson, S1
Fray, A1
Burtin, C1
Scheinmann, P1
Lespinats, G1
Canu, P1

Other Studies

2 other studies available for dimaprit and Experimental Neoplasms

ArticleYear
Role of histamine in natural killer cell-mediated resistance against tumor cells.
    Journal of immunology (Baltimore, Md. : 1950), 1990, Dec-15, Volume: 145, Issue:12

    Topics: Animals; Cytotoxicity, Immunologic; Dimaprit; Histamine; Immunity, Cellular; Interleukin-2; Killer C

1990
In vivo and in vitro anti-tumour activity of dimaprit.
    Agents and actions, 1985, Volume: 16, Issue:3-4

    Topics: Animals; Antineoplastic Agents; Cell Division; Cells, Cultured; Dimaprit; Female; In Vitro Technique

1985